Sera Prognostics(SERA) - 2025 Q4 - Annual Results

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2025 FINANCIAL RESULTS Salt Lake City – March 18, 2026 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year ended December 31, 2025. Key 2025 and Recent Highlights: Data Generation Commercial Progress Equity financing Exhibit 99.1 • Expanded Commercial Engage ...